跳到正文
原文
PhRMA· @PhRMA · X·· 13 天前AI 评分15
AI 导读

Fred曾接受自己永远无法获得肺纤维化的治疗帮助。 然后,在2025年10月,FDA批准了一种突破性疗法,而因为Fred住在美国,他很快就用上了。美国患者比其他国家的患者提前近3年获得新药。 告诉华盛顿让美国保持领先:https://ow.ly/zVHJ50ZOGxr

正文

Fred had accepted that he would never get help managing his pulmonary fibrosis.

Then, in October 2025, the FDA approved a breakthrough treatment, and because Fred lives in America, he got it fast. Patients in the US get new medicines nearly 3 years sooner than other countries.

Tell Washington to keep America in the lead: https://ow.ly/zVHJ50ZOGxr

来源:PhRMA · x.com